Disc Medicine, Inc. (IRON)
65.51
+0.73
(+1.13%)
USD |
NASDAQ |
Apr 02, 14:47
Disc Medicine EPS Diluted (Quarterly) : -1.618 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Boston Scientific Corp. | 0.4493 |
| Penumbra, Inc. | 1.202 |
| Amylyx Pharmaceuticals, Inc. | -0.3004 |
| Emergent BioSolutions, Inc. | -1.042 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.53M |
| Total Expenses (Quarterly) | 60.53M |
| Enterprise Value | 1.712B |
| Earnings Yield | -9.02% |
| Normalized Earnings Yield | -9.025 |